In this work, the effect of sintering parameters on electronic structure and physical properties of yttria-partially stabilized ZrO2 (YPSZ) commercial ceramics has been studied using the central composite design (CCD) method. The CCD method allows using empirical modelling with better fitting, by considering the interaction between both factors. Different temperature ranges and sintering times for processing of YPSZ ceramics have been used in order to evaluate the grain growth, hardness and volumetric shrinkage by the CCD method. X-ray diffraction patterns and Rietveld refinement data indicate that non-sintered YPSZ ceramics exhibits two phases related to tetragonal and monoclinic structures, while the sintered YPSZ ceramics exhibits a single phase related to a tetragonal structure. Moreover, the monoclinic structure presents zirconium (Zr) atoms coordinated to seven oxygen (O) atoms, while in the tetragonal structure Zr atoms are coordinated to eight O atoms. Field emission scanning electron microscopy images were employed to monitor the sintering and growth process. In addition, the response surfaces obtained from calculations presented the effect of thermal and kinetic variables on the physical properties such as average grain size, volumetric shrinkage and hardness of YPSZ ceramics.
Annona vepretorum Mart. (Annonaceae) is a species popularly known in Brazil as “araticum” and “pinha da Caatinga”. We have evaluated the antinociceptive effects of A. vepretorum in formalin-, capsaicin-, and glutamate-induced orofacial nociception in mice. Male Swiss mice were pretreated with either saline (p.o.), A. vepretorum ethanol extract (Av-EtOH 25, 50 and 100 mg/kg, p.o.), or morphine (10 mg/kg, i.p.), before formalin, capsaicin, or glutamate was injected into the right upper lip. Pre-treatment with Av-EtOH at all doses produced a reduction in face-rubbing behavior induced by formalin in both phases, and these pre-treatments also produced a significant antinociceptive effect in the capsaicin and glutamate tests. Pre-treatment with naloxone (1.5 mg/kg, i.p.) did not reverse the antinociceptive activity of the extract at the dose of 100 mg/kg in the first phase of this test. Our results suggest that Av-EtOH might be useful in the treatment of orofacial pain.